Status:
UNKNOWN
Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125
Lead Sponsor:
Beni-Suef University
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
45-50 years
Brief Summary
The investigators are assessing the incidence of ovarian cancer in premenopausal women who were at moderate risk of malignancy with low CA125.
Detailed Description
About 10% of premenopausal women may have a surgery for ovarian masses. In premenopausal women the incidence of ovarian malignancy is 1:1000 in case of symptomatic ovarian cyst.1 CA125 is unreliable i...
Eligibility Criteria
Inclusion
- Women with complex ovarian cyst
- Abdominal pain
- Menometrorrhagia
Exclusion
- Significant weight loss
- Cachexia
- History of ovarian or other malignancy
- Family history of ovarian Cancer
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02247323
Start Date
January 1 2016
End Date
December 1 2021
Last Update
February 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beni-Suef University
Cairo, Egypt